Protagenic Therapeutics, Inc.\new (PTIX) Consolidated Net Income (2013 - 2026)
Protagenic Therapeutics, Inc.\new (PTIX) posted Consolidated Net Income of -$963,616 for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$5.06 million a year earlier.
Protagenic Therapeutics, Inc.\new (PTIX) Consolidated Net Income (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Consolidated Net Income at Protagenic Therapeutics, Inc.\new was $5.46 million; for FY2026 (ended Mar 31, 2026), it was $1.37 million.
- In prior fiscal years, Protagenic Therapeutics, Inc.\new's Consolidated Net Income was -$3.59 million in FY2025, -$5.53 million in FY2024, -$5 million in FY2023 and -$3.56 million in FY2022.
- Quarterly Consolidated Net Income has run from a low of -$5.06 million in fiscal Q1 2026 to a high of $5.08 million in fiscal Q4 2026 over five years.
- According to Business Quant data, Consolidated Net Income for the three prior fiscal quarters was $5.08 million (Q4 2026), $2.21 million (Q3 2026) and -$869,496 (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Protagenic Therapeutics, Inc.\new | 1.30 Mn | 1.30 Mn | - | -963,616.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -963,616.00 |
| Mar 31, 2026 | 5.08 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Sep 30, 2025 | -869,496.00 |
| Jun 30, 2025 | -5.06 Mn |
| Mar 31, 2025 | -1.44 Mn |
| Dec 31, 2024 | -850,287.00 |
| Sep 30, 2024 | -582,387.00 |
| Jun 30, 2024 | -1.61 Mn |
| Mar 31, 2024 | -1.72 Mn |
| Dec 31, 2023 | -1.68 Mn |
| Sep 30, 2023 | -1.40 Mn |
| Jun 30, 2023 | -1.21 Mn |
| Mar 31, 2023 | -718,096.00 |
| Dec 31, 2022 | -601,374.00 |
| Sep 30, 2022 | -925,305.00 |
| Jun 30, 2022 | -666,717.00 |
| Mar 31, 2022 | -1.36 Mn |
| Dec 31, 2021 | -890,387.00 |
| Sep 30, 2021 | -878,299.00 |
Protagenic Therapeutics, Inc.\new Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PTIX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "PTIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=PTIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();